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PERBANDINGAN KECEKAPAN PAMERAN FAB DAN SCFV : APLIKASI 
FORMAT TERBAIK UNTUK PEMBANGUNAN ESEI IMUNO NOVEL 
BERASASKAN DNA G-KUADRUPLEKS 
 
ABSTRAK 
 
 Kebanyakan platform diagnostik konvensional lazimnya bergantung 
kepada antibodi monoklonal tikus yang tersedia ada dan khusus untuk kegunaan 
platform diagnostik seperti esei immuno dan aliran sisi. Namun, salah satu daripada 
isu yang terlibat dalam kaedah diagnostik konvensional adalah kepekaan dan 
ketersediaan biomolekul. Untuk mereka bentuk platform diagnostik, terdapat dua 
komponen utama yang perlu dipertimbangkan terutamanya pembangunan bio-
pengikat dan sistem pelapor. Bagi pembangunan bio-pengikat, antibodi rekombinan 
telah dipilih dengan menggunakan teknologi pameran faj. Perbandingan antara 
serpihan rantai tunggal boleh ubah (scFv) dan serpihan pengikat antigen (Fab) telah 
dianalisisdari segi pembangunan.identifikasi dan pengeluaran. Cabaran utama dalam 
penggunaan serpihan Fab adalah kerumitan pembentukan ikatan disulfida yang 
sering menyebabkan kecekapan paparan serpihan Fab dalam paparan faj lebih rendah 
jika dibandingkan dengan scFv. Oleh itu, molekul penghantar seperti DsbA dan 
DsbC yang dikodkan oleh plasmid pembantu, pTUM4 telah digunakan dalam kajian 
ini dengan tujuanmenambahbaikkan pembentukan ikatan disulfidauntuk membantu 
kecekapan pameran Fab atas partikel faj. Sehubungan dengan itu, pengubahsuaian 
dalam proses penyaringan dengan menggunakan sistem plasmid penolong turut 
dinilai serta digunakan untuk pembangunan antigen pengikat Fab tertentu. Di 
samping itu, proses penyaringan dengan menggunakan perpustakaan scFv juga 
xviii 
 
dilaksanakan. Walaupun pameran Fab atas partikel faj telah bertambah baik, format 
scFv didapati lebih berfaedah dalam proses pembangunan bio-pengikat berbanding 
dengan proses pembangunan bio-pengikat Fab dan hal ini telah membuat scFv lebih 
sesuai untuk digunakan dalam pembentukan esei imuno. Selain itu, esei imuno 
konvensional sering menggunakan konjugasi antibodi-enzim sebagai sistem pelapor 
yang sering mengalami masalah sensitiviti, kestabilan, ketahanan dan kos esei. 
Justeru, kaedah pengesanan baru telah diperkenalkan bagi menangani masalah-
masalah tersebut. Kebanyakan esei imuno menggunakan kaedah amplifikasi nukleik 
asid untuk meningkatkan kepekaan esei imuno. Pengikat scFv rekombinan yang 
terpilih telah berjaya diasimilasikan dalam esei imuno yang menggunakan G-
kuadrupleksDNAzimsebagai sistem pelapor. Kaedah “immuno-quadruplex priming 
amplification” (IQPA) ini menggunakan struktur G-kuadrupleks yang boleh 
memisahkan dirinya daripada templat semasa amplifikasi sebagai DNAzim untuk 
menjana bacaan kolorimetrik. Pengoptimuman esei ini telahmenyediakan bukti 
konsep platform tersebut dalam pembentukan esei imuno yang baru ini. Bagi IQPA 
secara langsung, had pengesanan esei tersebut didapati hany 0.5 µM, tetapi, bagi 
IQPA secara kompetitif, esei tersebut boleh mengesan antigen serendah 1 fM. 
Kesimpulannya, gabungan teknologi antibodi rekombinan dan DNA nanoteknologi 
dapat menyediakan saluran alternatif untuk pembentukan platform diagnostik baru 
yang mempunyai sensitiviti yang lebih baik dan mudah digunakan. 
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COMPARISON OF FAB AND SCFV PHAGE DISPLAY EFFICIENCY: 
APPLICATION OF BEST FORMAT FOR THE DEVELOPMENT OF A 
NOVEL DNA G-QUADRUPLEX BASED IMMUNOASSAY 
 
ABSTRACT 
 
The conventional diagnostic platforms are largely dependent on the availability of 
murine monoclonal antibodies and are designed to be used on platforms such as 
immunoassays and lateral flow. One of the main issues associated with conventional 
diagnostic methods is the sensitivity and availability of biomolecules. In designing a 
diagnostic platform, there are two main components that have to be considered. It is 
mainly the development of bio-binders and a reporter system. In the case of a bio-
binder development, recombinant antibodies were selected using phage display 
technology. A comparison between the scFv (single-chain fragment variable) and 
Fab (fragment of antigen binding) was carried out in terms of development, 
identification and production. The main challenge in using Fab fragments is the 
complexity of the disulphide bond formation that normally results in lower display 
efficiencies of Fab fragments during phage display. Therefore, in this study, 
molecular chaperones such as DsbA and DsbC that were encoded by the helper 
plasmid, pTUM4 were introduced in order to improve the disulphide bond formation 
to aid display efficiencies during phage display. A modified version of the panning 
using the helper plasmid system was evaluated and used for the development of 
antigen specific Fab binders. On the other hand, panning using scFv library was also 
carried out.  Although the presentation of Fab was improved, the scFv format was 
xx 
 
advantageous in the development process making it more ideal for immunoassay 
development. Conventional immunoassays often uses enzyme-conjugated secondary 
antibody as the reporter which sometimes suffers from sensitivity, stability, 
durability and the costs of the assay. Subsequently, new detection methods other than 
antibody-enzyme conjugates have been developed to counter these issues. Many 
have incorporated nucleic acid amplification methods into immunoassays with an 
amplification step for increased sensitivity. The recombinant scFv binder was 
successfully adapted to a novel immunoassay method which uses G-quadruplexes 
DNAzymes as the reporter system. The immuno-quadruplex priming amplification 
(IQPA) method uses self-dissociating G-quadruplex structures to function as 
DNAzymes to generate a colorimetric readout. Optimization of the assay provides a 
proof-of-concept of the platform for immunoassay development. In the direct IQPA, 
the limit of detection was found to be 0.5 µM, nevertheless, in competitive IQPA, it 
can detect as low as 1 fM of antigen. In conclusion, the fusion of recombinant 
antibody technology and DNA nanotechnology provides an alternative avenue for 
the development of novel diagnostic platforms with improved sensitivities and ease 
of use. 
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CHAPTER 1 
Introduction 
1.1 Immunoassay 
In the year 1960, immunoassay was first introduced by Berson and Yalow. 
They utilized radioisotopically labelled analytes as the reporter system by measuring 
the radioactivity of the bound analyte (Kahn & Roth, 2004; Yalow & Berson, 1960). 
Like all immunoassays, it is based on the quantification of the bound analyte to the 
specific antibody in the system. The use of radioisotopic label in immunoassays has 
given rise to many disadvantages which includes health hazards, stability of the 
radioisotope and the need of special requirements for licensing, handling and 
disposal of the radioisotopic substrates (Booth et al., 1982). 
With the advent of new technologies, the development of immunoassay has 
been greatly improved from the utilization of radioisotope labels to nonisotopic 
alternatives such as chromogenic, fluorogenic and chemiluminogenic substrates 
(Deshpande, 1996). In developing an immunoassay method, there are four main 
components that are taken into account: (a) the antibody used for detection, (b) the 
antigen to be detected, (c) the detection method and (d) the method to eliminate the 
unbound reactants. The most essential components of these four for a good 
immunoassay are the antibody and also the detection method (Andreotti et al., 2003; 
Koivunen & Krogsrud, 2006). Regardless of the immunoassay format, the specificity 
of the assay can be achieved with higher affinity antibodies. With higher affinity 
antibodies, antigen can be easily detected and the efficiency of the antibody-antigen 
complex formation can be increased tremendously (Liddell, 2013; Saerens et al., 
2008). Besides, the detection method used in an assay can affect the sensitivity level 
of the assay. The reactants can be detected visually, electronically, chemically or 
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physically depending on the nature of the signal produced. There is a wide range of 
instruments available to measure the signal produced with a high degree of 
sensitivity (Weeks et al., 2013).  
 
1.2 Bio-binders/Antibody 
Invasion of foreign molecules into the human body will trigger the immune 
system of the body to generate a response to shield it from being harmed by these 
invaders. The B lymphocytes will start to produce antibodies or also known as 
immunoglobulins to attack, kill or neutralize these foreign entities (Wood, 2006). 
Antibodies have the ability to recognize foreign molecules presented on the surface 
of the pathogens in the body. They are highly sought after because of their high 
specificity and affinity against target molecules. It is this feature that makes 
antibodies a useful tool for diagnostics and therapeutics (Filpula, 2007). 
An antibody is also known as immunoglobulin, in short, Ig which is produced 
by the B-lymphocytes. A basic antibody molecule is often depicted as a Y-shaped 
structure which is made up of four protein subunits (Wood, 2006). As shown in 
Figure 1.1, the two longer subunits are called the heavy chains while the shorter ones 
are called the light chains. The heavy chains and light chains are linked together by 
interchain disulphide bonds. It is also made up of repeating substructures called 
domains which are flanked by intrachain disulphide bonds. The domains at the C-
terminal are the constant domain as they do not differ much from antibody to 
antibody and some of the antibodies have the same amino acid sequences. Heavy 
chains have three to four constant domains while light chains have only one constant 
domain. On the other hand, the domains at the N-terminal ends of heavy chain and 
light chain are the variable domains because of the variability in amino acid  
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Figure 1.1 :  Illustration of Generic IgG Antibody Structure 
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sequence of these domains among the antibodies. These domains are made up of 
strands of the polypeptide chain that forms a pair of anti-parallel β-sheets, held 
together by a disulphide bond, surrounding a hydrophobic core in between these 
strands. These sheets then form a β-barrel structure known as immunoglobulin fold 
(Janeway et al., 2001).  
The variability is confined to three regions within each heavy chain and light 
chain. These regions are called the hyper variable regions or more commonly known 
as complementary determining regions (CDRs) (Liddell, 2013). The parts between 
the hyper-variable regions that do not differ much between antibodies are called the 
framework regions. These frameworks contribute to the overall structure of the 
antibody. It provides a framework on which the hyper-variable regions sit. Thus, 
when the protein folds, the three hyper-variable regions of each heavy and light chain 
are brought together at the end of the molecule and form the antigen binding sites or 
paratope (Wood, 2006). This site binds to a specific part of the antigen which is 
called the epitope as it is the complement to the shape of the epitope. As this antigen-
binding site is located at the variable domains of the heavy and light chains, different 
antibodies will have different antigen-binding sites consisting of different amino acid 
sequences against different antigens. Nevertheless, such variability ensures the total 
repertoire of the antibodies is sufficient to recognize any foreign entities or antigens 
that attack the body (Mian et al., 1991). 
 
1.3 Antibody Engineering 
The advent of recombinant antibody engineering has successfully allowed the 
introduction of engineered monoclonal antibody of smaller antibody fragments. The 
well-established antibody fragment is Fab (Fragment of antigen binding). It has a 
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complete set of light chains (VL and CL) paired with the variable domain and one of 
the constant domain of the heavy chain (VH and CH1), linked by the interchain 
disulphide bond (Janeway et al., 2001). The size of a Fab construct is at 
approximately 65 kDa which is double the the size of a scFv (Doshi et al., 2014). 
Thus, this can cause the display efficiency on phage to be less efficient compared to 
scFv display. Fab is lacking of a fragment consisting two constant domain of the 
heavy chain that has no antigen-binding activity, namely the Fc (fragment 
crystallisable). The Fab fragment is very much dependent on the formation of the 
interchain disulphide bond in between the CL and CH1. As the cytoplasm is in the 
reduced state that prevents the formation of the disulphide bridge, hence, the heavy 
chain (VH and CH1) and light chain (VL and CL) are expressed as two independent 
entities and is translocated to the the oxidizing periplasmic region where they can 
form disulphide bonds. Therefore, in the periplasmic region, the light chain will pair 
with the heavy chain and form the disulphide bond in between them, holding them 
together as one Fab construct (Barbas et al., 1991).The disulphide bond between the 
light and heavy chains plays an essential role for the stability of the Fab (Lilie et al., 
1995; Rothlisberger et al., 2005). For example, for IgG1, the disulphide bond is 
formed between the C-terminal cysteines of the CH1 domain at position H233 and 
light chain constant domain at position L214. For other Ig families or even other 
subtypes, the positions of cysteines of the CH1 differ, resulting in different location 
of the interchain disulphide bond. Even so, the spatial location of the chains is still 
able to command a similar backbone to the Ig fold (Loh et al., 2015; Rothlisberger et 
al., 2005). 
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Smaller fragments are engineered from Fab fragments such as scFv (single-
chain fragment variable). scFv is a truncated Fab that consists of the variable domain 
of a heavy chain and the light chain connected via a flexible polypeptide linker 
(Ewert et al., 2003). The polypeptide linker plays an essential role in the stability of 
the VH-VL interface of the scFv fragment. It may cause transient opening of the 
interface of the scFv, exposing the hydrophobic regions. This can lead to aggregation 
where the VH and VL domain will dissociate or even form dimers (Worn & 
Pluckthun, 2001). Therefore, the choice of a linker is very important in order to 
construct a stable scFv construct. There must be a certain degree of flexibility by the 
linkers that associate the VH and VL domains and form a functional VH-VL 
interface. For instance, the most commonly used flexible linker in constructing scFv 
is the glycine-serine (GGGS)n linker. This linker allows the mobility of the 
connecting VH-VL domain and at the same time, maintains its own stability in the 
aqueous solutions (Brichta et al., 2005; Chen et al., 2013).  Besides, the stability of 
the scFv construct is also depending on the intrinsically stable VH and VL domains 
which involves the intradomain disulphide bonds. The positions of the cysteines of 
the two variable domains are highly conserved which are at position H22/H92 and 
L23/L88 respectively. Though, the correct folding of the VH and VL domain 
respectively can also be achieved even without the good formation of disulphide 
bond. However, some reports have claimed that many scFv are not stable in the 
absence of the disulphide bond (Worn & Pluckthun, 2001).  
In order to acquire the stable and soluble antibody fragment, selection of such 
antibody fragments from large antibody libraries will have to be carried out. 
Generally, there are four types of libraries which are naïve, immune, semi-synthetic 
and synthetic antibody libraries. These libraries vary in their origins or source, their 
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library sizes, and diversity (Bahara et al., 2013; Mondon et al., 2008).  Naïve 
libraries are usually made from a naïve collection of antibody genes where it does 
not shown any preference in terms of diversity towards a particular antigen. The 
common source for naïve libraries are B-lymphocytes from healthy donors. 
Immunized libraries on the other hand are generated by a collection of skewed 
antibody genes generated as a response normally during infections. The source from 
which the genes can be derived from donors recently infected with a disease (Bazan 
et al., 2012; Kim et al., 2005). Synthetic antibody libraries are made up of a naïve 
repertoire but the genes are derived from a synthetic platform and not from 
lymphocytes. Generation of synthetic libraries involves random mutation of both 
variable heavy (VH) and variable light (VL) chain complementarity determining 
regions (CDRs) by using oligonucleotides resulting in a diverse repertoire of human 
VH and VL genes. The difference between the synthetic antibody and semi-synthetic 
antibody library is that semi-synthetic antibody combines natural CDRs and artificial 
ones instead of being fully synthetized (Ponsel et al., 2011).  
Nevertheless, the availability of these combinatorial libraries allows for the 
generation of engineered antibody with customized affinity and stability. There are 
various in vitro display technologies for selection of antibodies such as yeast display, 
phage display, ribosome display, mRNA display and bacterial display. Despite these 
technologies, antibody phage display, currently, is still the gold standard for 
recombinant antibody production due to its many success stories (Rakonjac et al., 
2011). 
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1.4 Phage Display Technology 
The developments in molecular biology have greatly improved the production 
of recombinant antibodies without the drawbacks of hybridoma technology using 
phage display. Phage display technology was first introduced by George Smith in the 
year 1985 (Smith & Petrenko, 1997). Phage display allows for the presentation of 
antibodies on phage surfaces that can be used to screen antigens using a process 
called biopanning (Barbas et al., 2004; Schirrmann et al., 2011). The biopanning 
process is a repetitive process that allows the enrichment and separation of specific 
antibodies by virtue of affinity. Therefore the availability of a combinatorial library 
on phage will allow the presentation of a diverse collection of antibody molecules in 
a small volume. This will allow easy isolation of monoclonal antibodies as phage 
display allows a physical interaction between the phenotype and genotype. Such 
technology has also lead to various techniques for screening and selection of the 
peptides and proteins, including antibodies against any target, specifically and with 
high affinity (Hust & Dübel, 2004; Schirrmann et al., 2011). 
 The bacteriophage that is mostly used in phage display technology is 
filamentous phage that can infect most Gram negative bacterias. M13 bacteriophage 
is the most widely used in this field. M13 phage is usually thin and cylindrical in 
shape with a single-stranded DNA genome as its genetic material that encodes for 5 
coat proteins, pIII, pVI, pVII, pVIII and pXIX (Gao et al., 1999). pIII and pVIII are 
the most commonly used to present the peptide or protein at the surface of the phage. 
pIII, which is encoded by gene 3 protein, can only display 3-5 copies of each peptide 
while pVIII, encoded by gene 8 protein, can display up to 2700 copies of peptide 
(Figure 1.2). The bacteria that the phage infects are bacteria only such as E.coli 
bacterial cells that have the F plasmid that encodes for the F-pilus. This allows 
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infection to occur, mediated by pIII coat protein of the phage which comprises of 
three domains such as N1, N2 and C. These phages will not lyse the cell after 
infection, unlike lytic phages. Instead, they keep replicating in the host cell and are 
released from the cell membrane, at the same time, the host cell continues to grow 
and divide (Rakonjac et al., 2011; Russel & Model, 2006). 
 During infection, the N2 domain of pIII of the phage will bind to the tip of 
the F-pilus of the bacterial cell. The pilus then, contracts to bring the phage into 
contact with a co-receptor, TolA, followed by the binding of the N1 domain to TolA 
in the periplasmic region of the cell. C domain of the pIII forms an α-helical structure 
which allows the entry of phage ssDNA into the cytoplasm. Upon infection, the 
phage ssDNA enters the cytoplasm and it is replicated by host enzymes while host 
cell growth continues. It commences with the synthesis of the negative (-) strand by 
RNA polymerase, generating a double-stranded replicative form(rf). PII which is the 
replication protein of the filamentous phage binds to the positive strand of the rf. It 
acts as a nickase as it makes a nick at the positive strand, binds to the 5’ end, leaving 
a free 3’ hydroxyl end to serve as a primer for the host DNA polymerase III to 
synthesize the new positive strand. The rf then undergoes rolling-circle replication of 
the positive strand.  The positive strand will be displaced as the replication starts. As 
each genome length is completed, it is cleaved by pII and then, the ends will be re-
ligated and circularized. As the copy number of dsDNA increase, the synthesis of 
phage encoded proteins will also increase. The positive strands are then coated by the 
pV protein with the ssDNA-binding protein serving as a packaging signal. Besides, 
pV also inhibits the translation of pII in order to stop the ssDNA replication process. 
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Figure 1.2 : M13 phage and its coat proteins (Gao et al., 1999). 
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The ssDNA-pV complex will give signal to the pI, pXI and pIV to form a phage 
export pore complex. PIV makes a channel in order to export the phages. At the same 
time, pVII and pIX will identify the phage ssDNA genomes to be packaged into the 
virions while pIII, pVI and pVIII are transported into the cytoplasmic membrane 
before the phage assembly. The ssDNA genome that is coated by pV will be replaced 
by pVIII as it passes through the membrane. After the completion of the protein 
assembly, the phage will pass through the pIV pore to emerge as mature phages and 
then, the pore is replugged by the pI and pXI without lysing the host cell (Russel et 
al., 2004; Sidhu, 2001). 
 In phage display technology, there are few types of pIII display systems such 
as Type 3, Type 33 or Type 3+3 (Paschke, 2006). The most commonly used system 
will be Type 3+3 and it requires a phagemid. Phagemid acts as a vector that consists 
of the origin of replication (ori) from the filamentous phage, the plasmid origin of 
replication of the E. coli, gene III or gene VIII protein, multiple cloning site (MCS), 
a promoter and also an antibiotic resistance gene (Mullen et al., 2006). The main two 
purpose of the phagemid is for cloning and also expression of desired protein on the 
phage’s surface. It can be grown as a plasmid in E. coli and a recombinant 
filamentous phage can be packaged with the aid of helper phages (Bradbury & Marks, 
2004; Paschke, 2006). Due to the insufficient amount of the filamentous phage genes 
that encodes for the structural and non-structural proteins in the genome, the helper 
phage is required to provide all of the necessary proteins for phage assembly. A 
phage display library that contains clones that carry different foreign DNA insert can 
be formed (Smith & Petrenko, 1997). 
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Proteins, in this case, antibodies will be presented at the coat protein of the 
phage. However, screening and selection of desired antibodies will have to be carried 
out by affinity selection on the immobilised target. This process is known as phage 
display panning (Figure 1.3). Targets will be immobilised and it is incubated with the 
phage library. The complementary protein presented on the phage will be bound and 
the unbound ones will be washed off. Then, the bound phages will be eluted and 
reinfected into E. coli for amplification. Basically, the panning process is a cycle 
where several rounds of panning and phage amplification are carried out as shown in 
Figure 1.3. Then, the protein or antibody presented will be analysed (Bazan et al., 
2012; Bradbury & Marks, 2004; Gao et al., 1999).  
 
1.5 Molecular Chaperones 
The protein aggregation and the inefficient folding of protein secreted by E. coli 
often occurs during protein expression especially when the nascent proteins that 
needed to be translocated to the periplasmic layer for proper folding of the protein 
(Missiakas & Raina, 1997). The antibody fragments are no exception to this 
especially the Fab fragment that requires the formation of disulphide bridge for 
proper folding (Plückthun, 1990). This is often the problems associated with Fab 
expression. In order to overcome these problems, molecular chaperones have been 
introduced during protein expression. Molecular chaperones are the protein 
components that participate in protein folding by assisting the nascent proteins to 
fold into their native fold, prevent aggregation of the protein and some protect the 
proteins from heat shock (Goemans et al., 2014; Hendrick & Hartl, 1995).  
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Figure 1.3 : Bio-panning or phage display panning cycle. 
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The ability to form disulphide bridges during protein folding is usually the rate-
limiting factor that results in inefficient protein folding and also decreases the yield 
of successfully folded proteins. Thus, recently, some molecular chaperones that 
catalyze the disulphide bridge formation have been recognized. As reported by 
Schlapschy et al., pTUM4 that encodes for few molecular chaperones such as DsbA, 
DsbC, FkpA and SurA was able to improve the formation of disulphide brigdes 
(Appendix G). DsbA and DsbC were able to catalyse the formation of disulphide 
bridge while FkpA and SurA help in increasing the yield of the protein produced 
(Schlapschy et al., 2006; Schlapschy & Skerra, 2011).  
 DsbA is a monomeric periplasmic protein that has two redox-active site 
cysteines residues present in a CXXC motif. This motif, more precisely, the Cys30, 
is in oxidised state at physiological pH, hence, the motif will be stabilized and this 
initiates the redox reaction of the DsbA and the substrate protein. As the unfolded 
substrate protein enters the periplasmic layer of bacteria, the oxidized DsbA will 
react with the substrate protein by transfering its disulphide to the adjacent cis-Pro 
motif of the substrate protein. After transferring its disulphide bond to the substrate 
protein, the reduced DsbA will be released and reoxidized by the membrane-boun 
protein, DsbB (Collet & Bardwell, 2002; Heras et al., 2007; Messens et al., 2007). 
After introducing the non-native disulphide bridge, DsbC will take part in the 
isomerization of the disulphide bridge. DsbC, a V-shaped form protein, comprises of 
a catalytic thioredoxin domain and a dimerization domain linked by a α-helix motif 
(Nakamoto & Bardwell, 2004). It has a hydrophobic surface which is believed to be 
the binding site of substrate proteins. DsbC is able to shuffle the disulphide bridge to 
the correct position in the substrate protein and isomerize it. This significant event 
has allowed the substrate protein to fold correctly. Nevertheless, the process time of 
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the oxidation-isomerization of the disulphide bridge is greatly reduced by both of 
these chaperones (Collet & Bardwell, 2002; Goemans et al., 2014; Heras et al., 2007).  
 FkpA and SurA, on the other hand, are also involved in the periplasmic 
protein folding pathway (Duguay & Silhavy, 2004). FkpA is described as a V-shaped 
homodimer, comprising of two domains such as the N-terminal domain that is 
involved in dimerization and the C-terminal domain is responsible for the peptidyl-
prolyl isomerase (PPIase) activity. Such PPIase activity catalyzes the cis/trans 
isomerization of the peptide bonds involving proline residues (Bothmann & 
Plückthun, 2000; Justice et al., 2005). Apart from that, FkpA acts as a folding 
enhancer during the protein folding activity. FkpA suppresses the formation of 
insoluble proteins in the periplasmic layer. In fact, FkpA does improve the yield of 
the protein expressed by E. coli (Schlapschy et al., 2006). 
SurA, which is originally known as a protein needed for survival, has being 
recognized as protein that exhibits the PPIase activity too. SurA comprises of a N-
terminal domain, two PPIase domain and a C-terminal helix domain. The N-terminal 
and C-terminal domain with one of the PPIase domain which has no PPIase activity 
forms a core structure that possesses the chaperone activity while the other PPIase 
domain is active in PPIase activity (Hennecke et al., 2005). SurA is involved in the 
assembly of the endogenous outer membrane porins which is essential for the cell. It 
can also promote the folding of the unstable proteins and prevents accumulation of 
misfolded proteins (Schlapschy et al., 2006). Although both FkpA and SurA can 
exhibit the PPIase activity, reports found that PPIase does not play an important role 
in increasing the rate of the periplasmic protein folding. However, SurA and FkpA 
can improve the efficiency of protein folding in the periplasmic area (Goemans et al., 
2014). 
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1.6 Reporter Systems 
The sensitivity of an immunoassay is not solely dependent on the antibody 
quality but also on the reporter system that is used. The detection of the reactants can 
be either visualized or measured by different instruments depending on the nature of 
the reporters. Many researchers or lab users utilize enzyme-labelled antibodies as the 
reporter to detect antigen. Such immunoassay is called the enzyme-linked 
immunosorbent assay (ELISA). This assay which was first introduced in the year of 
1971 by Engvall and Perlmann has now become a well-known diagnostic tool in 
clinic, plant pathology and food industry (Andreotti et al., 2003). This immunoassay 
may give rise to different signal sources such as colorimetry, fluorometry and 
chemiluminescence, depending on the substrate used in the assay. The enzyme-
labelled immunoassay with colormetric readout is one of the simplest assays to be 
carried out (Gan & Patel, 2013). The common enzymes used are the horseradish 
peroxidase and alkaline phosphatase. These enzymes act as catalyst in which they 
will convert the colourless substrate such as ABTS and TMB in the presence of 
hydrogen peroxide to a coloured end-product. These enzymes will keep on 
converting the substrate until a stopping reagent, for instance, acid, is added to stop 
the enzyme activity (Gan & Patel, 2013). In order to measure the intensity of the 
colour and estimate the concentration of the analyte, a spectrophotometer is required. 
However, the sensitivity of this immunoassay is still a limitation which led to the 
emergence of more sensitive indicators.  
 Fluorometric enzyme-labelled immunoassays utilizes enzyme to convert its 
substrate to a fluorescent end-product instead of a coloured end-product. 
Fluorophores in the substrate absorbs energy, in this case, light, at a specific 
wavelength and emit the light again at a longer wavelength. 4-methylumbelliferyl 
17 
 
phosphate (4-MUP) is the most widely used in fluorometric enzyme immunoassay 
while the enzyme label used is alkaline phosphatase. This enzyme will 
dephosphorylate 4-MUP to form 4-methylumbelliferone (4-MU) which acts a 
fluorophore in the assay. Then, it will excite the light at 365nm and emit at 448nm, 
measured using fluorescence spectrophotometer (Wild, 2005). Instead of using 
enzymes, a fluorophore can be directly labelled to the antibody such as fluorescent 
dyes by coupling chemistries or fluorescent protein by cloning. Such an assay is 
called the direct fluorescence immunoassay and it can also be designed into different 
formats too. The fluorescence signal given out is comparatively higher than the 
signal given out by colorimetric immunoassay. However, interferences may occur 
due to light scattering, background fluorescence and quenching of the sample used in 
the immunoassay. Light scattering and background fluorescence that is naturally 
present in biological samples can cause an increase in background reading. The 
signal can also be quenched by the sample and give rise to false negative result 
(Andreotti et al., 2003).  
 Compared to the colorimetric and fluorometric immunoassays, 
chemiluminescent immunoassays have achieved higher levels of sensitivity. It 
utilizes chemiluminescent compounds such as luminol, isoluminol and acridinium 
ester that can emit light as a result of a chemical reaction. Like the fluorometric 
immunoassays, chemiluminescent compounds can either be directly labelled to the 
analyte or used as a substrate in an enzyme-labelled immunoassay (Andreotti et al., 
2003). Chemiluminescence enzyme-labelled immunoassay utilizes an enzyme such 
as alkaline phosphatase to cleave the phosphate group of the chemiluminescent 
substrate, for example, adamantyl 1,2-dioxetane arylphosphate, and produce an 
unstable anion which then decays and causes the emission of light. Although the 
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enzymatic reactions may produce weak light emission which rapidly decays, the 
addition of another chemical such as hydrogen peroxide enables to enhance the light 
signal. The enhanced luminescence can persist for hours though the signal readout 
usually taken within minutes of the reaction (Weeks et al., 2013).  
 Apart from these immunoassays, many researchers used many new detection 
methods in order to amplify the signals and reduce the background reading (Weeks et 
al., 2013). Interference in fluorometric immunoassays that causes high background 
readout due to the protein or colloids can be circumvented using time-resolved 
fluorescence. The basic principle behind time-resolved fluorescence is having a time 
gap between excitation and measurement of the emitted light from the fluorophore. 
Therefore, the fluorophore used in this assay must have a longer decay time 
compared to the background fluorescence (Kwok & Chen, 2003; Liu et al., 2009). 
Lanthanides are the ideal fluorophores for this assay as they have an intense long-
lived fluorescence signal and a large Stokes shift (Tully & O’Kennedy, 2014). They 
can form fluorescent chelates with certain organic ligands. Signal can be strongly 
emitted when the lanthanides are excited at a specific wavelength of light. Due to its 
long-lived fluorescence, the lanthanides can be pulse-excited and generate 
accumulated signal which can enhance the signal strength of the assay (Andreotti et 
al., 2003).  
 
Some exploit the strong interaction of biotin and streptavidin in order to 
amplify the signal in an immunoassay (Koivunen & Krogsrud, 2006). Each 
streptavidin molecule possesses four binding sites for biotin and form a complex 
lattice. In the assay, the analyte is usually biotinylated whereas the streptavidin is 
conjugated with a signal-generating enzyme such as HRP and alkaline phosphatase. 
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The enzyme conjugated streptavidin will bind to the biotinylated analyte very 
quickly and form a complex lattice which can then amplify the signal produce in the 
assay (Andreotti et al., 2003). The interaction of streptavidin and biotin can be easily 
applied to any range of the immunoassay as long as the analyte is biotinylated. 
Utilization of the enzyme-conjugated streptavidin as a generic signal generation 
reagent has solved the need to develop different conjugation methods of the reagents 
that are used in different assay. 
In recent years, polymerase chain reaction has been successfully integrated into 
immunoassays that utilize DNA as a label bringing about Immuno-PCR (Niemeyer et 
al., 2015). With PCR, a million-fold increase in the number of copies of DNA can be 
obtained if the DNA is replicated in approximately 25 cycles. Thus, the amplification 
of the DNA can lower the detection limit of the assay. As such, further 
improvements of immunoassay, from using polymerase chain reaction to isothermal 
amplication, have been achieved too. A single temperature is needed to amplify the 
DNA using an incubator instead of a thermocycler can simplify the setting of the 
immunoassay and also lower the cost of it (Schweitzer et al., 2000). Another 
alternative DNA-label detection method without the need of PCR is the fluorophore 
DNA barcodes. The single-stranded fluorescent-labelled DNA and the analyte are 
coated to the microbeads. These microbeads are then allowed to bind to the ligand 
and the bound fluorescent-labelled DNA will be released and quantified. The signal 
can be amplified as there are many fluorophore-DNA molecules that are released 
from one microbead (Weeks et al., 2013). As this signal can only be quantified using 
a fluorescent spectrophotometer, thus, the discovery of DNA G-quadruplex that 
mimics the peroxidase activity can be used in immunoassay to  eliminate the need of 
fluorescent spectrophotometer (Ruttkay-Nedecky et al., 2013; Stefan et al., 2012). 
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Instead, it uses the UV spectrophotometer for quantitative analysis or using naked 
eyes for qualitative analysis. Nevertheless, the utilization of DNA as the reporter in 
immunoassays is the key for immunoassay improvements.  
 
1.7 Overview of DNA G-Quadruplex as Reporter System  
Deoxyribonucleic acid, DNA, plays a crucial role in storing genetic 
information of every living organism. DNA replication and transcription mechanisms 
have been well studied with many findings that show DNA to be a very dynamic 
molecule. It has the capability to form a number of spatial arrangements such as 
single-stranded hairpins, homoduplexes, triplexes and quadruplexes (Bochman et al., 
2012; Davis, 2004). Later findings had also show that these structures are involved in 
DNA recombination, regulation of gene expression and potentially proliferation of 
tumour cells. Therefore, researchers have grown interest in studying the structures of 
nucleic acids and their application in medical science. 
One of the DNA structures that is well studied is the G-quadruplex structure 
(Doluca et al., 2013). The structure comprises of a nucleic acid sequence rich in 
guanines (G). The typical base pairing in nucleic acid is called the Watson–Crick 
base-pairing which is the pairing of guanine and cytosine or adenine and thymine 
with hydrogen bond. However, nucleic acids can also be involved in another type of 
pairing known as Hoogsteen base pairing, allowing the formation of higher-order 
structures such as the quadruplex structures (Haider et al., 2011; Huppert, 2008; 
Keniry, 2000). This structure comprises of planar stacks of two or more of the G-
quartets that are joined by the phosphodiester backbone and is stabilized in the 
presence of specific cations. G-quartet is a square planar array that is formed by the 
linkage of four guanine bases. Many NMR and crystallographic studies have 
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reported that G-quadruaplexes are highly polymorphic (Adrian et al., 2012). They 
can form many different structural arrangements depending on the length of the 
DNA, orientation of the chains, positions of the loops and nature of the cations. 
Figure 1.4A shows some of the most common G-quadruplex structures such as 
parallel (tetramolecular), hairpin (bimolecular), basket and chair (unimolecular) 
(Burge et al., 2006). In recent years, the properties of the G-quadruplex have been 
well studied and some of the properties are exploited in many biological applications 
such as biosensor and therapeutic application (Liu et al., 2009).  
G-quadruplex is found to have the capability in generating enzymatic reaction 
and it is called the DNAzyme (Schlosser & Li, 2009). G-quadruplex DNAzymes, 
initially known as catalytic enzymes or DNA enzymes is able to exhibit catalytic 
capabilities as they can catalyze many reactions such as DNA modification, ligation, 
cleavage of DNA or RNA and also methylation of porphyrin rings (Breaker & Joyce, 
1994; Haider et al., 2011; Li et al., 2000; Li & Sen, 1996). Therefore, DNAzymes 
can be exploited into many applications especially in the field of medicine, biology 
and material sciences. The utilization of DNAzymes has many advantages as 
DNAzymes are stable in a broad range, even at high temperatures unlike the classical 
protein enzyme that is usually active in a narrow temperature range. Besides, they 
can be easily prepared by chemical synthesis and by PCR whereas protein enzymes 
require tedious preparation and purification. 
One of the most important features of DNAzyme activity of quadruplex-forming 
oligonucleotides is that it can mimic the peroxidase activity (Stefan et al., 2011). 
More precisely, this DNAzyme exhibits peroxidase activity when hemin is bound to 
the quadruplex (Kosman & Juskowiak, 2011; Saito et al., 2012). This complex 
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catalyzes the peroxide-mediated oxidation of the 2,2’-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) diammonium salt, in short ABTS (Figure1.4B).  
Thus, in the presence of H2O2, oxidation of the colorless ABTS will generate 
a colored product. This characteristic has enabled the use of DNAzyme as a reporter 
system in various assays as it also works well with TMB substrate. For instance, 
DNAzyme-functionalized gold nanoparticles (GNPs) used as nanoprobes in 
immunoassay to amplify detection of protein cancer biomarkers. A “sandwich-type” 
immunoassay with two types of probes was employed. One of the probes used is the 
magnetic microparticles (MMPs) functionalized with the protein cancer biomarker, 
α-fetoprotein (AFP) monoclonal antibodies for specific detection. Another probe is 
GNPs that are functionalized with double-stranded DNA and AFP polyclonal 
antibodies. Both GNPs and MMPs are mixed together in excess in order to capture 
the AFP effectively. These MMP-AFP-GNP complexes were collected magnetically 
and washed extensively. Then, the double stranded DNA on GNPs was denatured to 
form active DNAzymes in the presence of hemin and then reacted with ABTS as 
substrate (Zhou et al., 2009).   
Apart from the peroxidase activity, G-quadruplex can also enhance the 
fluorescence or luminescence signal to almost two- to ten-fold higher quantum yields. 
For example, a switch-on detection platform for human neutrophil elastase (HNE) 
has exploited the duplex-to-quaduplex conversion strategy with iridium (III) complex 
by using the G-quadruplex as the probe. First, the HNE aptamer was hybrized with 
the complementary DNA strand. The iridium (III) complex binds only weakly to the 
duplex, therefore, it emits a low lumiscence signal. The additional of the HNE 
protein causes the duplex structure to dissociate and form the HNE-aptamer-
quadruplex. Then, the iridium (III) complex strongly interacts with the newly formed  
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Figure 1.4 : A. Typical G-quadrplex structures B. Hemin is bound to the 
quadruplexes to acts as DNAzyme that can exhibit peroxidase activity. This complex 
catalyzes the peroxide-mediated oxidation of the 2,2’-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) diammonium salt (ABTS). In the presence of 
H2O2, oxidation of the colorless ABTS will generate a colored product. 
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quadruplex, resulting in an enhancement in luminescence signal (Ma et al., 2013). 
Nevertheless, the development of immunoassays using G-quadruplex structures as 
the reporter system have now gain a lot of attention as they can achieve catalysis 
with high accuracy, stability and reusability. 
 
1.8 Quadruplex Priming Amplification (QPA) 
QPA is a new method that involves isothermal amplification of a linear GGGT 
sequence that allows the formation of DNA quadruplexes in solution. QPA was 
designed under the fundamentals that free energy of DNA quadruplexes can be used 
to initiate endergonic reactions at constant temperatures. Different G-rich sequences 
are capable of forming quadruplexes with different preferential thermodynamics. 
QPA makes use of special primers that are designed with sequences that allow 
spontaneous dissociation from the hybridization site and fold into intramolecular 
quadruplexes in the presence of cations upon polymerase elongation. The primer, a 
complementary sequence of the template is designed with one or two guanine 
residues missing which allows self-dissociation from the template after elongation. 
The amplification begins with the binding of the primer to the template, forming a 
DNA duplex and the polymerase will start to elongate the primer. During the 
elongation, the 5’ end of the product will fold into an intramolecular quadruplex and 
self-dissociates, leaving its complementary template completely accessible to the 
incoming primer for the next priming cycle (Figure 1.5). This allows the continuous 
formation of quadruplex structures until all the primers are spent or the reaction is 
terminated (Johnson et al., 2013; Kankia, 2011; Taylor et al., 2013). To date, Kankia 
et al. had developed a fluoresecence based DNA detection method using QPA. 
However, this method has not been used for colorimetric based protein detection  
